Aichi, Japan

Hitoshi Kiyoi

USPTO Granted Patents = 8 


Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 57(Granted Patents)


Location History:

  • Nagoya, JP (2008 - 2018)
  • Aichi, JP (2006 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Hitoshi Kiyoi: Innovator in Cancer Treatment

Introduction

Hitoshi Kiyoi is a prominent inventor based in Aichi, Japan, known for his significant contributions to the field of cancer treatment. With a total of eight patents to his name, Kiyoi has focused on developing methods and pharmaceutical compositions aimed at diagnosing and treating malignant lymphoma and leukemia.

Latest Patents

Kiyoi's latest patents include a method for determining the presence or absence of suffering from malignant lymphoma or leukemia. This innovative method assists in identifying whether a subject is likely to suffer from these diseases by detecting specific genetic mutations. Additionally, he has developed a pharmaceutical composition that includes a DUX4 inhibitor, which is designed to treat and prevent malignant lymphoma or leukemia in subjects with certain genetic markers. Another notable patent involves a pharmaceutical composition for treating FLT3 mutation-positive cancer, which includes a mutant FLT3 inhibitor and methods for predicting therapeutic effects based on the presence of FLT3 mutations.

Career Highlights

Throughout his career, Kiyoi has worked with notable companies such as Chugai Seiyaku Kabushiki Kaisha and Kyowa Hakko Kirin Co., Limited. His work in these organizations has contributed to advancements in cancer research and treatment methodologies.

Collaborations

Kiyoi has collaborated with esteemed colleagues, including Tomoki Naoe and Hiroshi Umehara, to further enhance his research and development efforts in the medical field.

Conclusion

Hitoshi Kiyoi's innovative work in cancer treatment showcases his dedication to improving patient outcomes through advanced medical technologies. His contributions continue to influence the landscape of cancer research and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…